These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 14088841

  • 1. AN EVALUATION OF AB-103 (NSC-37096) IN THE PALLIATIVE MANAGEMENT OF ADVANCED GASTROINTESTINAL CARCINOMA.
    MOERTEL CG, REITEMEIER RJ, HAHN RG.
    Cancer Chemother Rep; 1963 Oct; 32():97-8. PubMed ID: 14088841
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CURRENT STATUS OF 5-FLUOROURACIL THERAPY IN FAR-ADVANCED NEOPLASTIC DISEASE.
    SCHELL HW.
    Geriatrics; 1964 Apr; 19():265-70. PubMed ID: 14141804
    [No Abstract] [Full Text] [Related]

  • 6. PHASE I STUDIES OF PYRAZOLE (NSC-45410).
    FOLEY HT, SHNIDER BI, GOLD GL, UZER Y.
    Cancer Chemother Rep; 1965 Feb; 44():45-8. PubMed ID: 14294812
    [No Abstract] [Full Text] [Related]

  • 7. TREATMENT OF ADVANCED CANCER WITH 5-FLUOROURACIL.
    HURLEY JD.
    Acta Unio Int Contra Cancrum; 1964 Feb; 20():363-5. PubMed ID: 14151930
    [No Abstract] [Full Text] [Related]

  • 8. TOXICITY AND CLINICAL TRIAL OF AZASERINE AND 6-THIOGUANINE IN ADVANCED SOLID MALIGNANT NEOPLASMS.
    SCHROEDER JM, ANSFIELD FJ, CURRERI AR, LEPAGE GA.
    Br J Cancer; 1964 Sep; 13(3):449-58. PubMed ID: 14219537
    [No Abstract] [Full Text] [Related]

  • 9. COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA.
    VELASCO HA, ROSS CA, WEBSTER JH, SOKAL JE, STUTZMAN L, AMBRUS JL.
    Cancer; 1964 Jul; 17():841-9. PubMed ID: 14184043
    [No Abstract] [Full Text] [Related]

  • 10. TESTOSTERONE ENANTHATE (NSC-17591) AS A BONE MARROW STIMULANT DURING CANCER CHEMOTHERAPY--PRELIMINARY REPORT.
    BRODSKY I, DENNIS LH, KAHN SB.
    Cancer Chemother Rep; 1964 Jan; 34():59-63. PubMed ID: 14116221
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
    Fink DJ, Foye LV.
    Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.